Inhibition of tumor cellular proteasome activity by triptolide extracted from the Chinese medicinal plant 'thunder...

Area of Science:

• Molecular Biology
• Cancer Research
• Pharmacology

Background:

• The ubiquitin/proteasome system is crucial for cellular protein degradation.
• Triptolide exhibits antitumor properties, but its precise molecular mechanisms remain unclear.
• Understanding triptolide's impact on proteasomal activity is key to its therapeutic potential.

Purpose of the Study:

• To investigate if triptolide inhibits proteasomal activity.
• To determine if triptolide induces apoptosis in human cancer cells.
• To elucidate the molecular mechanisms underlying triptolide's antitumor effects.

Main Methods:

• Assessed in vitro proteasome inhibition using purified 20S proteasome and triptolide.
• Treated human breast and prostate cancer cell lines with varying triptolide doses and durations.
• Measured proteasome activity, protein ubiquitination, proteasome target protein levels (p27, IκB-α, Bax), caspase-3 activity, and PARP cleavage.

Main Results:

• Triptolide did not directly inhibit the purified 20S proteasome's chymotrypsin-like activity.
• Triptolide treatment led to decreased cellular proteasomal chymotrypsin-like activity.
• Accumulation of ubiquitinated proteins and proteasome target proteins (p27, IκB-α, Bax) was observed, correlating with apoptosis induction.

Conclusions:

• Triptolide induces apoptosis in human cancer cells by affecting proteasome function.
• The observed proteasome inhibition is likely mediated by a triptolide metabolite.
• These findings highlight a potential therapeutic strategy targeting the ubiquitin/proteasome system in cancer treatment.